Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 144 articles: HTML format

Single Articles

May 2024
1. MULLER F, Mackensen A, Schett G
   CAR T-Cell Therapy in Autoimmune Disease. Reply.
   N Engl J Med. 2024;390:1631-1632.
   PubMed    
   
   
   
2. HOWARD JF JR, Vu T, Mozaffar T
   CAR T-Cell Therapy in Autoimmune Disease.
   N Engl J Med. 2024;390:1629-1631.
   PubMed    
   
   
   
3. DE BENEDETTI F, Diomedi Camassei F, Locatelli F
   CAR T-Cell Therapy in Autoimmune Disease.
   N Engl J Med. 2024;390:1629.
   PubMed    
   
   
   
4. MERKT W, Lorenz HM, Schmitt M
   CAR T-Cell Therapy in Autoimmune Disease.
   N Engl J Med. 2024;390:1628-1629.
   PubMed    
   
   
   April 2024
5. MATHUR M, Barratt J, Suzuki Y
   Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Reply.
   N Engl J Med. 2024;390:1245-1246.
   PubMed    
   
   
   
6. BELMONT HM
   Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
   N Engl J Med. 2024;390:1245.
   PubMed    
   
   
   
7. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
   Prevention of Cardiovascular Disease in Type 1 Diabetes.
   N Engl J Med. 2024;390:1207-1217.
   PubMed    
   
   
   March 2024
8. NETEA MG, van de Veerdonk FL
   Anti-Interleukin-23 Autoantibodies and Severe Infections.
   N Engl J Med. 2024;390:1143-1146.
   PubMed    
   
   
   
9. CHENG A, Kashyap A, Salvator H, Rosen LB, et al
   Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
   N Engl J Med. 2024;390:1105-1117.
   PubMed     Abstract available
   
   
   
10. DRIVENES JL, Bygum A
    Spontaneous Oral Purpura in Immune Thrombocytopenia.
    N Engl J Med. 2024;390:1029.
    PubMed    
    
    
    
11. WECHSLER ME, Nair P, Terrier B, Walz B, et al
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:911-921.
    PubMed     Abstract available
    
    
    February 2024
12. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    PubMed     Abstract available
    
    
    
13. ISAACS JD
    CAR T Cells - A New Horizon for Autoimmunity?
    N Engl J Med. 2024;390:758-759.
    PubMed    
    
    
    
14. HAUSER SL
    Silencing Immune Dialogue in Multiple Sclerosis.
    N Engl J Med. 2024;390:662-663.
    PubMed    
    
    
    
15. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    PubMed     Abstract available
    
    
    January 2024
16. DANDONA P, Chaudhuri A, Ghanim H
    More on Semaglutide in Early Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:292.
    PubMed    
    
    
    
17. GAGLIA JL, Laffel LM, Patti ME
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    PubMed    
    
    
    
18. WEINRAUCH LA, D'Elia JA
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    PubMed    
    
    
    
19. DEVRIES JH
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:290.
    PubMed    
    
    
    
20. HADZIC N, Deheragoda M, Worth A, Bansal S, et al
    JAK Inhibition in STAT1 Gain-of-Function-Mediated Treatment-Resistant Autoimmune Hepatitis.
    N Engl J Med. 2024;390:284-286.
    PubMed    
    
    
    
21. LEE TTM, Bergford S, Murphy HR
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:184.
    PubMed    
    
    
    
22. GRZYCH G, Kim I
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183-184.
    PubMed    
    
    
    
23. VIVANTI AJ, Benachi A, Voican A
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183.
    PubMed    
    
    
    
24. LEMLEY KV, Glassock RJ
    APRIL - Springtime for New IgA Nephropathy Therapy?
    N Engl J Med. 2024;390:80-81.
    PubMed    
    
    
    
25. LIU MJ, Li J
    Necrobiosis Lipoidica.
    N Engl J Med. 2024;390:70.
    PubMed    
    
    
    December 2023
26. ARJUNAN D, Bhadada SK
    Thyroid Dermopathy in Graves' Disease.
    N Engl J Med. 2023;389:2376.
    PubMed    
    
    
    
27. LUDVIGSSON J
    Immune Interventions at Onset of Type 1 Diabetes - Finally, a Bit of Hope.
    N Engl J Med. 2023;389:2199-2201.
    PubMed    
    
    
    
28. WAIBEL M, Wentworth JM, So M, Couper JJ, et al
    Baricitinib and beta-Cell Function in Patients with New-Onset Type 1 Diabetes.
    N Engl J Med. 2023;389:2140-2150.
    PubMed     Abstract available
    
    
    November 2023
29. EL-ZAATARI ZM
    Anti-Glomerular Basement Membrane Glomerulonephritis.
    N Engl J Med. 2023;389:1901.
    PubMed    
    
    
    
30. BUSSEL JB, Hou M, Cines DB
    Primary Immune Thrombocytopenia in Pregnancy. Reply.
    N Engl J Med. 2023;389:1728.
    PubMed    
    
    
    
31. TRAN BW, May KA, Pal N
    Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:1728.
    PubMed    
    
    
    
32. MATHUR M, Barratt J, Chacko B, Chan TM, et al
    A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
    N Engl J Med. 2023 Nov 2. doi: 10.1056/NEJMoa2305635.
    PubMed     Abstract available
    
    
    October 2023
33. RAMOS EL, Dayan CM, Chatenoud L, Sumnik Z, et al
    Teplizumab and beta-Cell Function in Newly Diagnosed Type 1 Diabetes.
    N Engl J Med. 2023 Oct 18. doi: 10.1056/NEJMoa2308743.
    PubMed     Abstract available
    
    
    
34. LINDHOFF-LAST E, Schonborn L, Zaninetti C, Warkentin TE, et al
    Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder.
    N Engl J Med. 2023;389:1339-1341.
    PubMed    
    
    
    
35. SPIERA RF, Unizony S, Warrington KJ, Sloane J, et al
    Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
    N Engl J Med. 2023;389:1263-1272.
    PubMed     Abstract available
    
    
    
36. LEE TTM, Collett C, Bergford S, Hartnell S, et al
    Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMoa2303911.
    PubMed     Abstract available
    
    
    
37. GARG SK, Polsky S
    Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMe2310798.
    PubMed    
    
    
    
38. ALETAHA D
    Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
    N Engl J Med. 2023;389:1328-1329.
    PubMed    
    
    
    September 2023
39. BRODERICK L, Kastner DL
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:1151-1152.
    PubMed    
    
    
    
40. PASTORE S, De Martino E, Taddio A
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome.
    N Engl J Med. 2023;389:1151.
    PubMed    
    
    
    
41. WANG WY, Cheng ST
    Sleeve Sign and Inverse Gottron's Papules in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2023;389:1032.
    PubMed    
    
    
    
42. DANDONA P, Chaudhuri A, Ghanim H
    Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2023;389:958-959.
    PubMed    
    
    
    August 2023
43. FUKUSHIMA H, Matsumoto M
    Cold Agglutinin Syndrome.
    N Engl J Med. 2023;389:642.
    PubMed    
    
    
    
44. BUSSEL JB, Hou M, Cines DB
    Management of Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:540-548.
    PubMed    
    
    
    
45. WARKENTIN TE, Baskin-Miller J, Raybould AL, Sheppard JI, et al
    Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.
    N Engl J Med. 2023;389:574-577.
    PubMed    
    
    
    
46. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    PubMed    
    
    
    
47. KOOSHESH KA, Foy BH, Sykes DB, Gustafsson K, et al
    Health Consequences of Thymus Removal in Adults.
    N Engl J Med. 2023;389:406-417.
    PubMed     Abstract available
    
    
    June 2023
48. WADWA RP, Beck RW, Breton MD
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:2206-2207.
    PubMed    
    
    
    
49. SHIBUE K
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2206.
    PubMed    
    
    
    
50. HSU NC, Hsu CH
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2205-2206.
    PubMed    
    
    
    
51. LEE CD, Galetta SL, Dobson R
    Management of Possible Multiple Sclerosis.
    N Engl J Med. 2023;388:2195-2198.
    PubMed    
    
    
    May 2023
52. BAGHDASSARIAN H, Blackstone SA, Clay OS, Philips R, et al
    Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
    N Engl J Med. 2023 May 31. doi: 10.1056/NEJMoa2202318.
    PubMed     Abstract available
    
    
    April 2023
53. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    PubMed    
    
    
    March 2023
54. BRUTTOMESSO D
    Technology in the Changing Management of Diabetes in Children.
    N Engl J Med. 2023;388:1052-1054.
    PubMed    
    
    
    
55. LEE AI, Heidari P, Fenves AZ, Bardia A, et al
    Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia.
    N Engl J Med. 2023;388:1032-1041.
    PubMed    
    
    
    
56. WADWA RP, Reed ZW, Buckingham BA, DeBoer MD, et al
    Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:991-1001.
    PubMed     Abstract available
    
    
    January 2023
57. RUSSELL SJ, Damiano ER, Calhoun P
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:380-382.
    PubMed    
    
    
    
58. KHOO TK
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    PubMed    
    
    
    
59. MURATA Y, Takita M, Kami M
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    PubMed    
    
    
    
60. AGGARWAL R, Charles-Schoeman C, Schessl J
    Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
    N Engl J Med. 2023;388:94-95.
    PubMed    
    
    
    
61. WERTH VP, Fiorentino DF, Vleugels RA
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2023;388:94.
    PubMed    
    
    
    November 2022
62. BURNSIDE MJ, Williman JA, de Bock MI
    Open-Source Automated Insulin Delivery in Type 1 Diabetes. Reply.
    N Engl J Med. 2022;387:2007-2008.
    PubMed    
    
    
    
63. SCARAMUZZA AE, Cherubini V, Rabbone I
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006-2007.
    PubMed    
    
    
    
64. MURATA Y, Takita M, Kami M
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006.
    PubMed    
    
    
    
65. BRENNAN T
    Pharmaceutical Marketing Revisited - United States v. Biogen Idec.
    N Engl J Med. 2022;387:1631-1633.
    PubMed    
    
    
    October 2022
66. WERTH VP, Barbey C, Franchimont N
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus. Reply.
    N Engl J Med. 2022;387:1529.
    PubMed    
    
    
    
67. PSARRAS A, Vital EM
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:1528-1529.
    PubMed    
    
    
    
68. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.
    PubMed    
    
    
    
69. AMATO AA
    Intravenous Immune Globulin Therapy in Dermatomyositis.
    N Engl J Med. 2022;387:1320-1321.
    PubMed    
    
    
    
70. AGGARWAL R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, et al
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2022;387:1264-1278.
    PubMed     Abstract available
    
    
    
71. LEELARATHNA L, Evans ML, Neupane S, Rayman G, et al
    Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
    N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMoa2205650.
    PubMed     Abstract available
    
    
    September 2022
72. RUSSELL SJ, Beck RW, Damiano ER, El-Khatib FH, et al
    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2022;387:1161-1172.
    PubMed     Abstract available
    
    
    
73. COLIZZO FP, Shroff SG, High FA, Chen YB, et al
    Case 29-2022: A 33-Year-Old Man with Chronic Diarrhea and Autoimmune Enteropathy.
    N Engl J Med. 2022;387:1124-1134.
    PubMed    
    
    
    
74. HERRERA-COMOGLIO R, Lane S
    Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210813.
    PubMed    
    
    
    
75. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    PubMed     Abstract available
    
    
    
76. BOLINDER J
    CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    N Engl J Med. 2022;387:937-938.
    PubMed    
    
    
    
77. BOUGHTON CK, Allen JM, Ware J, Wilinska ME, et al
    Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    N Engl J Med. 2022;387:882-893.
    PubMed     Abstract available
    
    
    
78. BURNSIDE MJ, Lewis DM, Crocket HR, Meier RA, et al
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:869-881.
    PubMed     Abstract available
    
    
    August 2022
79. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.
    PubMed     Abstract available
    
    
    
80. WINGERCHUK DM, Lucchinetti CF
    Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2022;387:631-639.
    PubMed    
    
    
    July 2022
81. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    PubMed     Abstract available
    
    
    June 2022
82. KUTER DJ
    Rilzabrutinib in Immune Thrombocytopenia. Reply.
    N Engl J Med. 2022;386:2538.
    PubMed    
    
    
    
83. MURAKAMI J, Senoo Y, Tanimoto T
    Rilzabrutinib in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:2537-2538.
    PubMed    
    
    
    
84. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    PubMed    
    
    
    
85. HUANG YM, Lin PH
    IgG4-Related Ophthalmic Disease.
    N Engl J Med. 2022;386:2315.
    PubMed    
    
    
    
86. JEBARAJ A, Lin A
    Sclerokeratitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:2221.
    PubMed    
    
    
    April 2022
87. WARE J, Hovorka R
    Closed-Loop Control in Very Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2022;386:1482-1483.
    PubMed    
    
    
    
88. RING BL
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    PubMed    
    
    
    
89. MURATA Y, Takita M, Kami M
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    PubMed    
    
    
    
90. KUTER DJ, Efraim M, Mayer J, Trneny M, et al
    Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:1421-1431.
    PubMed     Abstract available
    
    
    March 2022
91. SPERLING MA, Laffel LM
    Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
    N Engl J Med. 2022;386:1155-1164.
    PubMed    
    
    
    
92. COSTENBADER KH
    A New IMiD for Systemic Lupus Erythematosus - Tempering Our Excitement.
    N Engl J Med. 2022;386:1085-1086.
    PubMed    
    
    
    
93. MERRILL JT, Werth VP, Furie R, van Vollenhoven R, et al
    Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
    N Engl J Med. 2022;386:1034-1045.
    PubMed     Abstract available
    
    
    January 2022
94. YONG GY, Lim AL
    Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:374.
    PubMed    
    
    
    
95. WARE J, Allen JM, Boughton CK, Wilinska ME, et al
    Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:209-219.
    PubMed     Abstract available
    
    
    
96. VIDENOVIC A, Babu S, Zhao B, Reda HM, et al
    Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.
    N Engl J Med. 2022;386:173-180.
    PubMed    
    
    
    
97. PAVORD S, Lester W, Hunt BJ
    Clinical Features of VITT. Reply.
    N Engl J Med. 2022;386.
    PubMed    
    
    
    
98. CHITI A
    Clinical Features of VITT.
    N Engl J Med. 2022;386.
    PubMed    
    
    
    December 2021
99. LACY J, Pavord S, Brown KE
    VITT and Second Doses of Covid-19 Vaccine.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
    PubMed    
    
    
    
100. DILLY B, Bomahou C
     Tongue Necrosis in Giant-Cell Arteritis.
     N Engl J Med. 2021;385:2377.
     PubMed    
     
     
     
101. BRADBURY CA, Hill Q, Greenwood R
     Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
     N Engl J Med. 2021;385:2201-2202.
     PubMed    
     
     
     
102. VAN DIJK WEM, Schutgens REG
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2201.
     PubMed    
     
     
     
103. GHANIMA W, Zaja F, Michel M
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2200-2201.
     PubMed    
     
     
     
104. CHEN S, Dong C, Wei JC
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2200.
     PubMed    
     
     
     November 2021
105. O'CONNELL J, Nathan DM, O'Brien T, O'Keeffe DT, et al
     Treatment of Diabetes - To Pump or Not to Pump.
     N Engl J Med. 2021;385:2092-2095.
     PubMed    
     
     
     
106. MANDL A, Burbelo PD, Di Pasquale G, Tay YS, et al
     Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
     N Engl J Med. 2021;385:1974-1980.
     PubMed     Abstract available
     
     
     
107. BJORNSTAD P, Drews K, Zeitler PS
     Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
     N Engl J Med. 2021;385:2016.
     PubMed    
     
     
     
108. NELSON RG, Hanson RL, Knowler WC
     Long-Term Complications in Youth-Onset Type 2 Diabetes.
     N Engl J Med. 2021;385:2015.
     PubMed    
     
     
     
109. YANG W, Wang C
     Long-Term Complications in Youth-Onset Type 2 Diabetes.
     N Engl J Med. 2021;385:2014-2015.
     PubMed    
     
     
     
110. MOUGIAKAKOS D, Kronke G, Schett G
     More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
     N Engl J Med. 2021;385:e67.
     PubMed    
     
     
     
111. KONIG MF, Paul S
     More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
     N Engl J Med. 2021;385:e67.
     PubMed    
     
     
     
112. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
     Decline in Pathogenic Antibodies over Time in VITT.
     N Engl J Med. 2021;385:1815-1816.
     PubMed    
     
     
     October 2021
113. BERENTSEN S, Barcellini W
     Autoimmune Hemolytic Anemias.
     N Engl J Med. 2021;385:1407-1419.
     PubMed    
     
     
     September 2021
114. MATTHIESEN MI, Shailam R, Rothermel H
     Case 29-2021: A 12-Month-Old Boy with Fever and Developmental Regression.
     N Engl J Med. 2021;385:1220-1229.
     PubMed    
     
     
     
115. TSUI JC, Onishi S
     Symblepharon in Linear IgA Bullous Dermatosis.
     N Engl J Med. 2021;385:1219.
     PubMed    
     
     
     
116. WERTH VP, Joly P, Chen DM
     Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
     N Engl J Med. 2021;385:1056.
     PubMed    
     
     
     
117. HOPKINS ZH, Wu BC, Nousari CH
     Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
     N Engl J Med. 2021;385:1055-1056.
     PubMed    
     
     
     
118. BOLTON-MAGGS PHB, George JN
     Immune Thrombocytopenia Treatment.
     N Engl J Med. 2021;385:948-950.
     PubMed    
     
     
     
119. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
     Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
     N Engl J Med. 2021;385:885-895.
     PubMed     Abstract available
     
     
     August 2021
120. PAVORD S, Scully M, Hunt BJ, Lester W, et al
     Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
     N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
     PubMed     Abstract available
     
     
     
121. GOYAL RK
     Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
     N Engl J Med. 2021;385:576.
     PubMed    
     
     
     
122. AKTURK HK, Shah VN
     Gastric Emptying Abnormalities in Diabetes Mellitus.
     N Engl J Med. 2021;385:575-576.
     PubMed    
     
     
     
123. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
     CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
     N Engl J Med. 2021;385:567-569.
     PubMed    
     
     
     July 2021
124. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
     Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
     N Engl J Med. 2021;385:451-460.
     PubMed    
     
     
     
125. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
     A Periodic Problem.
     N Engl J Med. 2021;385:e17.
     PubMed    
     
     
     
126. AVELAR RODRIGUEZ D, Orkin J
     An Icteric Tongue.
     N Engl J Med. 2021;385:e16.
     PubMed    
     
     
     
127. MORAN-THOMAS A
     One Hundred Years of Insulin for Some.
     N Engl J Med. 2021;385:293-295.
     PubMed    
     
     
     
128. GOGLIN SE, Margaretten ME
     Malar Rash.
     N Engl J Med. 2021;385:164.
     PubMed    
     
     
     
129. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
     Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
     N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
     PubMed    
     
     
     June 2021
130. O'CONNELL KA, LaChance AH
     Dermatomyositis.
     N Engl J Med. 2021;384:2437.
     PubMed    
     
     
     
131. SEEKER P, Osswald S
     Tongue Discoloration.
     N Engl J Med. 2021;384:e102.
     PubMed    
     
     
     
132. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
     Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
     N Engl J Med. 2021;384:2295-2305.
     PubMed     Abstract available
     
     
     May 2021
133. JAYNE DRW, Merkel PA, Bekker P
     Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
134. MATSUO Y, Miyabe Y
     Avacopan for the Treatment of ANCA-Associated Vasculitis.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
135. CHANDWAR K
     Avacopan for the Treatment of ANCA-Associated Vasculitis.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
136. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
     A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
     N Engl J Med. 2021;384:2014-2027.
     PubMed     Abstract available
     
     
     
137. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
     Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
     N Engl J Med. 2021;384:1849-1857.
     PubMed    
     
     
     
138. FRALICK M, Sarma S
     Thyrotoxic Periodic Paralysis.
     N Engl J Med. 2021;384:e71.
     PubMed    
     
     
     
139. MOHAMED F, Raal FJ
     Hyperpigmentation from Addison's Disease.
     N Engl J Med. 2021;384:1752.
     PubMed    
     
     
     April 2021
140. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
     Case 13-2021: A Newborn Girl with a Neck Mass.
     N Engl J Med. 2021;384:1647-1655.
     PubMed    
     
     
     
141. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
     Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
     N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
     PubMed     Abstract available
     
     
     
142. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
     Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
     N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
     PubMed     Abstract available
     
     
     
143. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
     Sutimlimab in Cold Agglutinin Disease.
     N Engl J Med. 2021;384:1323-1334.
     PubMed     Abstract available
     
     
     
144. ZONOZI R, Niles JL
     Sunken Nose.
     N Engl J Med. 2021;384:e52.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.